Modalis Therapeutics has made significant strides in developing a gene therapy technology aimed at treating LAMA2-congenital muscular dystrophy (LAMA2-CMD). Earlier…
LAMA2-France and Partners launch landmark LAMA2-CMD natural history study in France. The first French natural history study focused on LAMA2-CMD…
Whilst there are currently no available treatments for LAMA2-CMD, several potential therapeutic approaches are under development and investigation. This article…
SEAL Therapeutics was established in late 2021 by Prof. Markus Rüegg, Dr. Judith Reinhard, both from the Biozentrum, and Dr.…
Heavyweight kickboxing world champion Rico Verhoeven met up with some of the LAMA2-CMD family in The Netherlands last December 2023. …
Meet 25-year-old Mo and 16-year-old Hidde from The Netherlands, both living with LAMA2-CMD. In this short documentary produced by the…
